Free Trial

electroCore (ECOR) Competitors

electroCore logo
$7.10 +1.01 (+16.58%)
As of 04:00 PM Eastern

ECOR vs. CVRX, LNSR, AVR, PDEX, RCEL, INFU, LUCD, LAKE, PTHL, and OBIO

Should you be buying electroCore stock or one of its competitors? The main competitors of electroCore include CVRx (CVRX), LENSAR (LNSR), Anteris Technologies Global (AVR), Pro-Dex (PDEX), Avita Medical (RCEL), InfuSystem (INFU), Lucid Diagnostics (LUCD), Lakeland Industries (LAKE), Pheton (PTHL), and Orchestra BioMed (OBIO). These companies are all part of the "medical equipment" industry.

electroCore vs. Its Competitors

electroCore (NASDAQ:ECOR) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, media sentiment, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends.

electroCore has a net margin of -46.24% compared to CVRx's net margin of -97.49%. CVRx's return on equity of -79.04% beat electroCore's return on equity.

Company Net Margins Return on Equity Return on Assets
electroCore-46.24% -149.04% -61.24%
CVRx -97.49%-79.04%-42.37%

electroCore has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Comparatively, CVRx has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500.

electroCore currently has a consensus price target of $25.50, suggesting a potential upside of 259.15%. CVRx has a consensus price target of $14.50, suggesting a potential upside of 114.81%. Given electroCore's stronger consensus rating and higher possible upside, equities research analysts clearly believe electroCore is more favorable than CVRx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
electroCore
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
CVRx
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.71

electroCore has higher earnings, but lower revenue than CVRx. electroCore is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
electroCore$25.18M2.09-$11.89M-$1.56-4.55
CVRx$51.29M3.43-$59.97M-$2.18-3.10

In the previous week, CVRx had 1 more articles in the media than electroCore. MarketBeat recorded 1 mentions for CVRx and 0 mentions for electroCore. CVRx's average media sentiment score of 0.26 beat electroCore's score of 0.00 indicating that CVRx is being referred to more favorably in the news media.

Company Overall Sentiment
electroCore Neutral
CVRx Neutral

26.7% of electroCore shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 19.7% of electroCore shares are owned by insiders. Comparatively, 18.9% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

CVRx beats electroCore on 10 of the 16 factors compared between the two stocks.

Get electroCore News Delivered to You Automatically

Sign up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ECOR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ECOR vs. The Competition

MetricelectroCoreMED IndustryMedical SectorNASDAQ Exchange
Market Cap$52.68M$2.37B$5.47B$8.92B
Dividend YieldN/A1.78%5.24%4.04%
P/E Ratio-4.558.9227.0520.14
Price / Sales2.09501.68380.7693.83
Price / CashN/A21.7726.2128.59
Price / Book6.284.528.005.58
Net Income-$11.89M$31.26M$3.16B$248.40M
7 Day Performance35.50%6.11%3.84%6.13%
1 Month Performance23.91%5.75%3.04%7.78%
1 Year Performance11.11%1.24%34.26%20.95%

electroCore Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ECOR
electroCore
2.315 of 5 stars
$7.10
+16.6%
$25.50
+259.2%
-4.7%$52.68M$25.18M-4.5550High Trading Volume
CVRX
CVRx
2.7544 of 5 stars
$5.88
+1.0%
$14.50
+146.6%
-46.7%$151.74M$51.29M-2.70160
LNSR
LENSAR
1.3791 of 5 stars
$13.17
+3.2%
$15.00
+13.9%
+187.2%$150.47M$53.49M-2.72110
AVR
Anteris Technologies Global
N/A$3.79
-6.7%
$16.50
+335.4%
N/A$146.41M$2.70M0.00138Positive News
PDEX
Pro-Dex
2.4712 of 5 stars
$43.64
-2.8%
$56.00
+28.3%
+164.9%$146.36M$53.84M15.59140High Trading Volume
RCEL
Avita Medical
0.8547 of 5 stars
$5.29
-2.9%
$16.50
+211.9%
-35.9%$144.07M$64.25M-2.42130
INFU
InfuSystem
1.9282 of 5 stars
$6.24
+2.0%
$13.00
+108.3%
N/A$131.14M$137.58M104.02410High Trading Volume
LUCD
Lucid Diagnostics
2.1584 of 5 stars
$1.15
-1.7%
$3.55
+208.7%
+31.8%$126.58M$4.35M-0.8670Positive News
LAKE
Lakeland Industries
4.8235 of 5 stars
$13.61
+3.3%
$26.00
+91.0%
-37.0%$125.40M$167.21M-4.522,100High Trading Volume
PTHL
Pheton
N/A$18.39
+0.8%
N/AN/A$120.06M$450K0.0011High Trading Volume
OBIO
Orchestra BioMed
2.6504 of 5 stars
$2.68
-3.6%
$14.20
+429.9%
-64.2%$106.51M$2.64M-1.514High Trading Volume

Related Companies and Tools


This page (NASDAQ:ECOR) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners